We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

177 hedge funds and large institutions have $2.92B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more call options, than puts

Call options by funds: $165M | Put options by funds: $31.7M

105% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 20

29% more capital invested

Capital invested by funds: $2.27B → $2.92B (+$653M)

14% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 59

13% more funds holding

Funds holding: 157 → 177 (+20)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
177
Holders Change
+20
Holders Change %
+12.74%
% of All Funds
4.77%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
41
Increased
67
Reduced
59
Closed
20
Calls
$165M
Puts
$31.7M
Net Calls
+$133M
Net Calls Change
+$91.7M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$79.4M
2
JHIU
Janus Henderson Investors US
Colorado
+$77.8M
3
Invesco
Invesco
Georgia
+$14.2M
4
NCGI
Next Century Growth Investors
Minnesota
+$13.6M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$48M
2
BBA
Baker Bros. Advisors
New York
-$38M
3
KCM
Kingdon Capital Management
New York
-$29.6M
4
FCM
Farallon Capital Management
California
-$26.2M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$22M
Name Holding Trade Value Shares
Change 		Change in
Stake
HMS
176
Hanseatic Management Services
New Mexico
$1K +$852 +13 New
CCM
177
Consonance Capital Management
New York
– -$48M -830,151 Closed
PHS
178
PFM Health Sciences
California
– -$20M -346,314 Closed
CCM
179
Cadian Capital Management
New York
– -$14.4M -220,000 Closed
BC
180
Broadfin Capital
New York
– -$10.7M -184,320 Closed
CS
181
Candriam SCA
Luxembourg
– -$2.89M -50,000 Closed
Norges Bank
182
Norges Bank
Norway
– -$2.41M -41,615 Closed
CIP
183
Convergence Investment Partners
Florida
– -$1.81M -31,262 Closed
CCM
184
Cadence Capital Management
Massachusetts
– -$1.31M -22,710 Closed
EI
185
EAM Investors
California
– -$987K -17,070 Closed
TI
186
Turner Investments
Pennsylvania
– -$874K -15,100 Closed
NI
187
Numeric Investors
Massachusetts
– -$856K -14,800 Closed
Voloridge Investment Management
188
Voloridge Investment Management
Florida
– -$835K -14,435 Closed
PCM
189
Price Capital Management
Louisiana
– -$740K -12,787 Closed
PIM
190
Partner Investment Management
California
– -$499K -8,627 Closed
Los Angeles Capital Management
191
Los Angeles Capital Management
California
– -$387K -6,695 Closed
DIA
192
Denver Investment Advisors
Colorado
– -$324K -5,597 Closed
Creative Planning
193
Creative Planning
Kansas
– -$191K -3,300 Closed
JG
194
Jefferies Group
New York
– -$117K -2,022 Closed
FMA
195
FNY Managed Accounts
New York
– -$57.9K -1,000 Closed
FNYS
196
First New York Securities
New York
– -$2.02K -35 Closed
KCPG
197
Kavar Capital Partners Group
Kansas
– +$328 +5 New
4 5 6 7
8

ANAC Hedge Fund Activity: Q2 2015 in Review

177 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2015, worth a combined $2.92B — up 29% from $2.27B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ANAC positions and 20 closed out — a net gain of 21 holders — while 67 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $79.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $48M sold.

  • 177 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2015, up from 157 in Q1 2015.
  • Funds reported $2.92B of ANACOR PHARMACEUTICALS INC COM stock for Q2 2015, up 29% quarter-over-quarter.
  • 41 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2015 and 20 closed out, a net change of +21 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2015 was Fidelity Investments, an estimated $79.4M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2015 was Consonance Capital Management, an estimated $48M sold.

Based on aggregated 13F filings for Q2 2015.